Pulmonary Hypertension Clinical Trials in Ann Arbor, Michigan

3 studies are recruiting for pulmonary hypertension in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan - Michigan Medicine, Ann Arbor, Michigan
    Locations
    37 in total
    Run by
    Tempus AI
  2. A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Clinical Research Site, Ann Arbor, Michigan
    Locations
    13 in total
    Run by
    Pulmovant, Inc.
  3. An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    23 in total
    Run by
    Liquidia Technologies, Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.